Press Release

Radiofrequency Ablation (RFA) Devices Market to Flourish with Surging Chronic Disease Prevalence Globally

The Global Radiofrequency Ablation (RFA) Devices Market is projected to grow at a CAGR of 9.37% during the forecast period of 2024-30, cites MarkNtel Advisors in the recent research report. The increasing number of patients with cancer, and cardiovascular diseases (CVDs) who are recommended for provision of radiofrequency ablation treatment as an additional measure has been driving the global market for Radiofrequency Ablation (RFA) Devices. Also, with the increasing burden of the geriatric population, the incidence of multiple diseases, including cancer, cardiovascular diseases (CVDs), chronic pain, etc., is expected to increase tremendously across the world. This is further expected to support the adoption of radiofrequency ablation devices for disease treatment, propelling the global radiofrequency ablation devices market.

Additionally, a notable market trend regarding the incorporation of advanced imaging technologies to enhance procedural precision has emerged in the Global Radiofrequency Ablation (RFA) Devices Market. These technologies encompass real-time ultrasound, fluoroscopy, and Magnetic Resonance Imaging (MRI) guidance, enabling superior visualization of target tissues and adjacent structures during RFA procedures. By providing surgeons with instantaneous feedback and precise localization of the treatment area, these advanced imaging tools bolster the safety and effectiveness of RFA procedures while minimizing harm to surrounding healthy tissue.

This shift towards integrated imaging solutions would not only elevate patient outcomes but would also foster the continuous expansion and adoption of RFA as a favored minimally invasive treatment approach across various medical disciplines, including oncology, pain management, and cardiology. Consequently, the global market for radiofrequency ablation devices is poised for growth in the foreseeable future, further states the research report, “Global Radiofrequency Ablation (RFA) Devices Market Analysis, 2024.”

Global Radiofrequency Ablation (RFA) Devices Market Segmentation Analysis

Radiofrequency Generators Segment Dominated the Global Radiofrequency Ablation (RFA) Devices Market

Based on the product type, the market is further categorized into Radiofrequency Generators and Consumables. Radiofrequency Generators is estimated to have the largest market share over the past years. Radiofrequency ablation (RFA) generators drive the industry through continuous technological advancements, expand applications across medical specialties, and increase demand for minimally invasive procedures. These generators offer enhanced procedural efficiency, precision, and safety, catering to patients and healthcare providers' growing preference for less invasive treatment options. Additionally, the growing focus on making RFA generators more accessible and affordable for people is also fuelling the market growth.

North America Witnessed Considerable Growth in the Global Radiofrequency Ablation (RFA) Devices Market

In the dynamic landscape of the Global Radiofrequency Ablation Devices Market, North America has experienced substantial growth in recent years. The dominance has been attributed to the presence of key players, product launches, well-established healthcare infrastructure, government initiatives, etc. Further, there has been a high prevalence of chronic diseases, such as cancer, cardiovascular diseases (CVDs), etc., across the region.

Thus, with an increasing number of patients with cancer in North America, the demand for radiofrequency ablation devices that are considered standard treatment, specifically for liver cancer, would increase. Also, the region’s growing old population at risk for multiple diseases is further expected to drive the growth of the North American Radiofrequency Ablation Devices market.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market players, including Boston Scientific Corporation, Pajunk, Abbott, Medtronic, Stryker, BIOTRONIK Schweiz AG, AngioDynamics, CONMED Corporation, Lepu Medical Technology(Beijing)Co., Ltd., Arthrex, Inc., STARmed Co., Ltd., AVNS, Olympus, BVM Medical Limited (RF Medical), Johnson & Johnson Services, Inc., etc., are looking forward to strengthening their market position.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the Global Radiofrequency Ablation (RFA) Devices Market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping across various regions?
6. How has the buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2019-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?